Partial nephrectomy, known for its comparable therapeutic efficacy to radical nephrectomy and its potential to lower the occurrence of postoperative chronic kidney disease, consequently reducing the risk of cardiovascular and cerebrovascular complications as well as mortality associated with chronic kidney disease, has been established as the standard surgical procedure for early-stage kidney cancer treatment in academic and clinical circles.[8, 9]
In traditional partial nephrectomy, in order to create a relatively bloodless surgical field to ensure complete tumor resection and wound closure, it is often necessary to block the renal artery. However, this can result in renal warm ischemia-reperfusion injury and may affect the patient’s short-term and long-term renal function.[10, 11] Previous studies have shown that each minute of warm ischemia time can impact long-term renal function.[12] Therefore, many scholars have conducted research on reduction of warm ischemia-reperfusion injury, and have proposed various methods to shorten warm ischemia time. These methods include intraoperative hypothermia with ice water,[13] microwave/radiofrequency-assisted partial nephrectomy,[14] and highly selective renal artery occlusion.[15] In 2011, Gill et al. first proposed the concept of "zero ischemia" partial nephrectomy, which means not blocking the renal artery before tumor resection, fundamentally avoiding the warm ischemia time and maximizing the protection of renal function.[16] However, zero-ischemia partial nephrectomy requires high demands on preoperative preparation and the skills of the surgeon. Therefore, the precise identification of tumor-feeding vessels preoperatively and the accurate control of these vessels intraoperatively become crucial aspects of this surgery.
Currently, in clinical practice, the assessment of renal tumors and surrounding anatomical structures heavily relies on two-dimensional imaging information from CT or MRI scans. These images are displayed in black and white, and are limited in perspective, lacking three-dimensional depth perception. Three-dimensional reconstruction technology involves the process of creating a complete three-dimensional image by overlaying continuous two-dimensional images using computer-aided design software. This technology emerged in the 1980s and 1990s, initially finding application in the industrial sector before gaining widespread use in the medical field due to its distinct advantages.[17-19] In a 3D reconstruction model different tissue structures are marked with various colors and transparencies, enabling clinicians to accurately understand the anatomy of the tumor and surrounding tissues. This technology allows for various degrees of zooming, rotation, and transparency adjustments, facilitating the precise identification of key information such as tumor size, location, depth of infiltration, relationship with the collecting system, vascular distribution, and adjacency to surrounding organs.[20] The application of this technology in the field of renal tumors is still in its preliminary exploration stage. In 2014, SIBER-STEIN et al. from Duke University successfully utilized three-dimensional reconstruction technology to print the world's first renal tumor model. This model matches the size of the patient's affected kidney, including the major vascular structures, renal pelvis, and proximal ureter, with the tumor being differentiated by a distinct color from the renal parenchyma. It effectively displays the relationship between the tumor and the kidney, facilitating preoperative tumor localization, aiding in surgical planning, and enhancing preoperative communication.[21]
In this study, we employed a three-dimensional renal tumor-targeted vascular reconstruction technique. Patients underwent preoperative comprehensive CTA examination, followed by three-dimensional reconstruction using software to localize the renal tumor-targeted blood vessels. This approach optimized the surgical treatment plan, guided intraoperative procedures, and facilitated precise handling of the tumor-targeted blood vessels. Ultimately, it enabled the achievement of zero-ischemia preservation of the renal unit during laparoscopic surgery. In the zero ischemia group, there were 4 cases of T1b renal cell carcinoma located in the lower pole of the kidney. Preoperative three-dimensional renal tumor vascular reconstruction evaluated the tumor vasculature as multi-targeted. The plan was to perform laparoscopic partial nephrectomy without renal artery clamping. However, significant bleeding occurred during the operation, leading to mid-procedure renal artery clamping and subsequent partial nephrectomy. The remaining 26 patients successfully underwent zero-ischemia laparoscopic partial nephrectomy, with no occurrences of urinary leakage or bleeding complications during the perioperative period. Postoperative follow-up results revealed no cases of positive surgical margins or local recurrence. Patients in the traditional surgery group all underwent successful laparoscopic partial nephrectomy without conversion to open surgery or radical nephrectomy. In the comparison of serum creatinine levels at 3 and 12 months postoperatively between two patient groups, no statistically significant differences were observed. However, a significant difference was noted in the comparison of GFR at 3 months postoperatively, indicating a faster recovery of renal function in patients undergoing partial nephrectomy under zero ischemia using renal tumor-targeted vascular localization. At the 12-month follow-up, no tumor recurrence or metastasis was observed in either group. While statistically significant variances were found in surgical time and intraoperative blood loss between the two groups, the length of hospital stay and the incidence of postoperative complications showed no statistically significant differences. These findings suggest that employing renal tumor-targeted vascular localization for zero ischemia partial nephrectomy under laparoscopy does not increase perioperative risks compared to laparoscopic surgery with complete renal artery occlusion and kidney unit preservation, thus demonstrating the safety and efficacy of this approach.
Based on previous clinical experience, most physicians consider the surgical removal of renal hilar tumors to be challenging and unsuitable for zero ischemia partial nephrectomy. Therefore, this study analyzed the target blood vessels of tumors in different locations within the zero ischemia group. In comparison to the tumor target vessels of renal pole tumors, those of renal hilar tumors are mostly single and relatively large, making it easier to locate and block them during surgery. Additionally, 4 cases in the zero ischemia group were converted to artery blocking laparoscopic partial nephrectomy due to heavy bleeding. Their tumors were located at the lower pole of the kidney and had a diameter greater than 4cm with multiple tumor target vessels. This suggests that the renal tumor target vessel localization method is particularly suitable for patients with single early-stage renal cancer in the renal hilar region.
In clinical practice, we believe that three-dimensional reconstruction offers several advantages in guiding zero-ischemia LPN. Firstly, as opposed to traditional methods where the operating physician obtains information from two-dimensional CTA images and relies on spatial imagination to understand the anatomical features of the kidney and tumor, three-dimensional reconstruction provides a more intuitive display of the anatomical structures and adjacent relationships of the kidney, tumor, and their surrounding vascular systems. This enhances the amount of information obtained by the operating physician during preoperative image review. By reviewing three-dimensional reconstruction models before the procedure, the surgeon can more accurately and quickly locate the tumor during surgery and precisely control the tumor's blood supply during excision. Secondly, three-dimensional reconstruction can be employed through data analysis and reconstruction processes to understand the situation of tumor-feeding blood vessels. In zero-ischemia LPN surgery, early control of tumor-feeding blood vessels can effectively reduce intraoperative bleeding and provide a better surgical field of view, thereby enhancing the success rate of zero-ischemia LPN. Thirdly, three-dimensional reconstruction visually displays the tumor morphology, aiding in precise tumor resection and reducing positive margin rates. Previous research results have shown that three-dimensional reconstruction models, due to their intuitive, clear, and visual advantages, can reduce positive margin rates of surgical specimens in robot-assisted radical prostatectomy and partial nephrectomy. As certain kidney tumors may exhibit irregular growth patterns or satellite foci, the use of three-dimensional reconstructed images allows the lead surgeon to assess tumor morphology and satellite foci preoperatively, thereby reducing positive margin rates. In addition, in actual clinical practice, we have found that three-dimensional reconstruction images not only aid in preoperative assessment and the formulation of surgical plans, but also, due to their intuitive and visual nature, can be used for preoperative patient education and discussions, facilitating a better understanding of the condition and surgical aspects for patients and their families, thereby enhancing their comprehension of the disease and their cooperation with treatment.
Certainly, not all cases of renal tumors are suitable for this technique. When implementing the renal tumor targeted vascular embolization technique for zero ischemia laparoscopic partial nephrectomy, the following points should be noted: ① For exophytic tumor patients, it is recommended that the exophytic portion of the tumor be greater than 50%, with an optimal tumor diameter between 2 to 5 cm; ② This method is recommended for solitary tumors and tumors located at the renal hilum; ③ In order to avoid excessive intraoperative bleeding that cannot be controlled, it is advisable to routinely pre-separate the renal artery as a backup during the procedure.
The present study also has certain limitations. Firstly, as the three-dimensional renal tumor target vessel reconstruction technology is based on preoperative CTA examination, it is not suitable for renal tumor patients who are allergic to contrast agents or have impaired renal function and therefore cannot undergo CTA. Secondly, this study included cases with an average maximum tumor diameter of 4.8cm, and it remains to be further verified whether patients with larger tumor diameters, such as cT1b stage tumors, can benefit from this technique. Thirdly, due to the current limitations of the technology, real-time synchronous reconstruction models with the surgical field have not yet been achieved, thus the role of this technology in real-time intraoperative localization and navigation is still lacking. Furthermore, this study only provides a single-center small sample retrospective experience, and the relevant conclusions still require further validation through advanced-level research.
In conclusion, for some early-stage renal cancer patients, the application of three-dimensional renal tumor target vessel reconstruction technology can better achieve ‘zero-ischemia’ laparoscopic partial nephrectomy, which is beneficial for the preservation of renal function in patients. The target vessels of the solitary early-stage renal cancer in the renal hilum are relatively easy to locate, making it more suitable for the implementation of three-dimensional renal tumor target vessel reconstruction technology for performing ‘zero-ischemia’ laparoscopic partial nephrectomy.